Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function

Behavioural Brain Research

Volumn 312, Issue , 2016, Pages 102-117

  Too, Lay Khoon ^a   Li, Kong M ^b   Suarna, Cacang ^c,d   Maghzal, Ghassan J ^c,d   Stocker, Roland ^c,d   McGregor, Iain S ^a   Hunt, Nicholas H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

5 Hydroxytryptamine; Behavior; Cognition; Indoleamine 2,3 dioxygenase; IntelliCage; Tryptophan 2,3 dioxygenase

Indexed keywords

SEROTONIN; DOPAMINE; IDO1 PROTEIN, MOUSE; IDO2 PROTEIN, MOUSE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CIRCADIAN RHYTHM; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINE METABOLISM; EXPERIMENTAL BEHAVIORAL TEST; EXPERIMENTAL COGNITIVE TEST; EXPLORATORY BEHAVIOR; FEMALE; GENE; GENE DELETION; GENE FUNCTION; HYPOACTIVITY; IDO 1 GENE; IDO 2 GENE; MALE; MENTAL PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REFERENCE MEMORY; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; TDO2 GENE; ANIMAL; ANIMAL BEHAVIOR; BRAIN; C57BL MOUSE; GENETICS; LEARNING; LOCOMOTION; METABOLISM; PHYSIOLOGY; SHORT TERM MEMORY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CIRCADIAN RHYTHM; COGNITION; DOPAMINE; EXPLORATORY BEHAVIOR; FEMALE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; LEARNING; LOCOMOTION; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

EID: 84976292414     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2016.06.018     Document Type: Article

References (43)

1. [1] Ruddick, J.P., Evans, A.K., Nutt, D.J., Lightman, S.L., Rook, G.A., Lowry, C.A., Tryptophan metabolism in the central nervous system: medical implications. Expert Rev. Mol. Med. 8 (2006), 1–27.
2. [2] Schwarcz, R., Bruno, J.P., Muchowski, P.J., Wu, H.Q., Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 13 (2012), 465–477.
3. [3] Bonner, D.M., Yanofsky, C., The biosyntheses of tryptophan and niacin and their relationships. J. Nutr. 44 (1951), 603–616.
4. [4] Moffett, J.R., Namboodiri, M.A., Tryptophan and the immune response. Immunol. Cell Biol. 81 (2003), 247–265.
5. [5] Ball, H.J., Sanchez-Perez, A., Weiser, S., Austin, C.J., Astelbauer, F., Miu, J., et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396 (2007), 203–213.
6. [6] Metz, R., Duhadaway, J.B., Kamasani, U., Laury-Kleintop, L., Muller, A.J., Prendergast, G.C., Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67 (2007), 7082–7087.
7. [7] Yuasa, H.J., Takubo, M., Takahashi, A., Hasegawa, T., Noma, H., Suzuki, T., Evolution of vertebrate indoleamine 2,3-dioxygenases. J. Mol. Evol. 65 (2007), 705–714.
8. [8] Metz, R., Smith, C., DuHadaway, J.B., Chandler, P., Baban, B., Merlo, L.M., et al. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int. Immunol. 26 (2014), 357–367.
9. [9] Merlo, L.M., Pigott, E., DuHadaway, J.B., Grabler, S., Metz, R., Prendergast, G.C., et al. IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis. J. Immunol. 192 (2014), 2082–2090.
10. [10] Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., et al. Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol. Brain, 2, 2009, 8.
11. [11] Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008), 46–56.
12. [12] O'Connor, J.C., Lawson, M.A., Andre, C., Briley, E.M., Szegedi, S.S., Lestage, J., et al. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J. Immunol. 182 (2009), 3202–3212.
13. [13] O'Connor, J.C., Lawson, M.A., Andre, C., Moreau, M., Lestage, J., Castanon, N., et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 14 (2009), 511–522.
14. [14] Barichello, T., Generoso, J.S., Simoes, L.R., Elias, S.G., Tashiro, M.H., Dominguini, D., et al. Inhibition of indoleamine 2,3-dioxygenase prevented cognitive impairment in adult Wistar rats subjected to pneumococcal meningitis. Transl. Res. 162 (2013), 390–397.
15. [15] Salazar, A., Gonzalez-Rivera, B.L., Redus, L., Parrott, J.M., O'Connor, J.C., Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Horm. Behav. 62 (2012), 202–209.
16. [16] Too, L.K., McQuillan, J.A., Ball, H.J., Kanai, M., Nakamura, T., Funakoshi, H., et al. The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis. Behav. Brain Res. 270 (2014), 179–195.
17. [17] Wu, H.Q., Rassoulpour, A., Schwarcz, R., Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain. J. Neural Transm. 114 (2007), 33–41.
18. [18] Kurachi, M., Sumiyoshi, T., Shibata, R., Sun, Y.J., Uehara, T., Tanii, Y., et al. Changes in limbic dopamine metabolism following quinolinic acid lesions of the left entorhinal cortex in rats. Psychiatry Clin. Neurosci. 54 (2000), 83–89.
19. [19] Zinger, A., Barcia, C., Herrero, M.T., Guillemin, G.J., The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease. Parkinsons Dis., 2011, 2011, 716859.
20. [20] Knox, W.E., Two mechanisms which increase in vivo the liver tryptophan peroxidase activity: specific enzyme adaptation and stimulation of the pituitary adrenal system. Br. J. Exp. Pathol. 32 (1951), 462–469.
21. [21] Yoshida, R., Hayaishi, O., Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 75 (1978), 3998–4000.
22. [22] Werner-Felmayer, G., Werner, E.R., Fuchs, D., Hausen, A., Reibnegger, G., Wachter, H., Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res. 50 (1990), 2863–2867.
23. [23] Mellor, A.L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171 (2003), 1652–1655.
24. [24] Too, L.K., Ball, H.J., McGregor, I.S., Hunt, N.H., A novel automated test battery reveals enduring behavioural alterations and cognitive impairments in survivors of murine pneumococcal meningitis. Brain Behav. Immun. 35 (2014), 107–124.
25. [25] Too, L.K., Ball, H.J., McGregor, I.S., Hunt, N.H., The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis. Brain Behav. Immun. 40 (2014), 252–268.
26. [26] Too, L.K., Mitchell, A.J., Yau, B., Ball, H.J., McGregor, I.S., Hunt, N.H., Interleukin-18 deficiency and its long-term behavioural and cognitive impacts in a murine model of pneumococcal meningitis. Behav. Brain Res. 263C (2014), 176–189.
27. [27] Lipp, H.-P., Litvin, O., Galsworthy, M., Vyssotski, D.L., Vyssotski, A.L., Zinn, P., Rau, A.E., Neuhäusser-Wespy, F., Würbel, H., Nitsch, R., Wolfer, D.P., Automated behavioral analysis of mice using INTELLICAGE: Inter-laboratory comparisons and validation with exploratory behavior and spatial learning. Noldus, L.P.J.J., et al. (eds.) Proceedings of Measuring Behavior, 2005, Noldus Information Technology, Netherlands.
28. [28] Krackow, S., Vannoni, E., Codita, A., Mohammed, A.H., Cirulli, F., Branchi, I., et al. Consistent behavioral phenotype differences between inbred mouse strains in the IntelliCage. Genes Brain Behav. 9 (2010), 722–731.
29. [29] Van Loo, P.L., Van Zutphen, L.F., Baumans, V., Male management: coping with aggression problems in male laboratory mice. Lab. Anim. 37 (2003), 300–313.
30. [30] L.K. Too, K.M. Li, C. Suarna, G.J. Maghzal, R. Stocker, I.S. McGregor, et al. Behavioral and cognitive abilities vary according to the genetic background of mice with different tryptophan-metabolising enzymes knocked out. Data in Brief submitted.
31. [31] Mazarei, G., Neal, S.J., Becanovic, K., Luthi-Carter, R., Simpson, E.M., Leavitt, B.R., Expression analysis of novel striatal-enriched genes in Huntington disease. Hum. Mol. Genet. 19 (2010), 609–622.
32. [32] Mazarei, G., Budac, D.P., Lu, G., Lee, H., Moller, T., Leavitt, B.R., The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain. Exp. Neurol. 249 (2013), 144–148.
33. [33] Fonio, E., Benjamini, Y., Golani, I., Short and long term measures of anxiety exhibit opposite results. PLoS One, 7, 2012, e48414.
34. [34] Albert, P.R., Vahid-Ansari, F., Luckhart, C., Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression. Front. Behav. Neurosci., 8, 2014, 199.
35. [35] Millan, M.J., The role of monoamines in the actions of established and novel antidepressant agents: a critical review. Eur. J. Pharmacol. 500 (2004), 371–384.
36. [36] Fatokun, A.A., Hunt, N.H., Ball, H.J., Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids. 45 (2013), 1319–1329.
37. [37] Pantouris, G., Serys, M., Yuasa, H.J., Ball, H.J., Mowat, C.G., Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1. Amino Acids 46 (2014), 2155–2163.
38. [38] Martin, S., Jones, M., Simpson, E., van den Buuse, M., Impaired spatial reference memory in aromatase-deficient (ArKO) mice. Neuroreport 14 (2003), 1979–1982.
39. [39] Galani, R., Obis, S., Coutureau, E., Jarrard, L., Cassel, J.C., A comparison of the effects of fimbria-fornix, hippocampal, or entorhinal cortex lesions on spatial reference and working memory in rats: short versus long postsurgical recovery period. Neurobiol. Learn Mem. 77 (2002), 1–16.
40. [40] Pothuizen, H.H., Zhang, W.N., Jongen-Relo, A.L., Feldon, J., Yee, B.K., Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur. J. Neurosci. 19 (2004), 705–712.
41. [41] Bannerman, D.M., Rawlins, J.N., McHugh, S.B., Deacon, R.M., Yee, B.K., Bast, T., et al. Regional dissociations within the hippocampus–memory and anxiety. Neurosci. Biobehav. Rev. 28 (2004), 273–283.
42. [42] Ward, B.O., Wilkinson, L.S., Robbins, T.W., Everitt, B.J., Forebrain serotonin depletion facilitates the acquisition and performance of a conditional visual discrimination task in rats. Behav. Brain Res. 100 (1999), 51–65.
43. [43] Harrison, A.A., Everitt, B.J., Robbins, T.W., Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav. Brain Res. 100 (1999), 99–112.